- Home
- QNRX vs NUWE Comparison
QNRX vs NUWE Comparison
Compare QNRX & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- NUWE
- Stock Information
- Founded
- QNRX 2018
- NUWE 1999
- Country
- QNRX United States
- NUWE United States
- Employees
- QNRX N/A
- NUWE N/A
- Industry
- QNRX Medical/Dental Instruments
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- QNRX Health Care
- NUWE Health Care
- Exchange
- QNRX Nasdaq
- NUWE Nasdaq
- Market Cap
- QNRX 2.5M
- NUWE 3.9M
- IPO Year
- QNRX N/A
- NUWE N/A
- Fundamental
- Price
- QNRX $7.12
- NUWE $1.00
- Analyst Decision
- QNRX
- NUWE Strong Buy
- Analyst Count
- QNRX 0
- NUWE 1
- Target Price
- QNRX N/A
- NUWE $17.00
- AVG Volume (30 Days)
- QNRX 355.0K
- NUWE 66.4K
- Earning Date
- QNRX 05-08-2025
- NUWE 05-06-2025
- Dividend Yield
- QNRX N/A
- NUWE N/A
- EPS Growth
- QNRX N/A
- NUWE N/A
- EPS
- QNRX N/A
- NUWE N/A
- Revenue
- QNRX N/A
- NUWE $8,740,000.00
- Revenue This Year
- QNRX N/A
- NUWE $22.96
- Revenue Next Year
- QNRX N/A
- NUWE $29.97
- P/E Ratio
- QNRX N/A
- NUWE N/A
- Revenue Growth
- QNRX N/A
- NUWE N/A
- 52 Week Low
- QNRX $5.01
- NUWE $0.75
- 52 Week High
- QNRX $54.95
- NUWE $12.60
- Technical
- Relative Strength Index (RSI)
- QNRX 46.54
- NUWE 53.14
- Support Level
- QNRX $5.27
- NUWE $0.86
- Resistance Level
- QNRX $7.22
- NUWE $0.95
- Average True Range (ATR)
- QNRX 1.12
- NUWE 0.08
- MACD
- QNRX 0.22
- NUWE 0.02
- Stochastic Oscillator
- QNRX 62.79
- NUWE 92.59
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.